Companies · Other Health Care

Check-Cap Ltd

ISFIYA · Other Health Care

Diligence memoA one-page analyst read on Check-Cap Ltd — recommendation, valuation, rhythm, risks.
$26.0M
Total raised · real
6
Rounds
3.2×
Latest step-up
Top 14%
Sector rank · raised
Series A
Latest stage · inferred · Thu Jul 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Check-Cap Ltd looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.89× the median modeled value of Series A Other Health Care companies in 2019–2021 (164 peers) — value vs value, same stage and era.
Dormant
  • Last raise 5.9 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Check-Cap Ltd is one of 5377 Other Health Care companies tracked from ISFIYA. By capital raised it ranks in the upper tier (ahead of 87% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
9
Investors (latest)
2020-07-23
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeed · 2017-05-29 Raised $2.7M (real) Modeled valuation $67M (est)$2.7M$67MSeed2017Seed · 2017-11-20 Raised $2.1M (real) Modeled valuation $53M (est)$2.1M$53MSeed2017Series A · 2020-04-20 Raised $4.0M (real) Modeled valuation $81M (est)$4.0M$81MSeries A2020Series A · 2020-04-30 Raised $4.5M (real) Modeled valuation $91M (est)$4.5M$91MSeries A2020Series A · 2020-05-08 Raised $3.0M (real) Modeled valuation $61M (est)$3.0M$61MSeries A2020Series A · 2020-07-23 Raised $9.6M (real) Modeled valuation $190M (est)$9.6M$190MSeries A2020+$2.1M+$4.0M+$4.5M+$3.0M+$9.6MCumulative $26M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.7M · 2017
Seed extension$2.1M · 2017
Series A$4.0M · 2020
Series A extension$4.5M · 2020
Series A extension$3.0M · 2020
Series A extension$9.6M · 2020

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$190.3M
Base estimate est.
$12.3M
Conservative case
$1.0B
Upside case
$43.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $66.9M · 2017-05-292017Seed · modeled $52.8M · 2017-11-20Series A · modeled $80.7M · 2020-04-20Series A · modeled $90.8M · 2020-04-30Series A · modeled $60.5M · 2020-05-08Series A · modeled $190.3M · 2020-07-232020
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
5.9 yr
Elapsed time used
5.9 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
8 mo
Avg between rounds
$8.2M/yr
Capital velocity
9.1 yr
On record since
2017
First round
6
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 11× above median
This company$26.0M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 1.7× above median
This company$9.6M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 8.6× above median
This company$190.3M
Sector median$22.1M

Raised more than 87% of sector peers (real $). Modeled value above 87% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #20 of 164.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)InvestCo Tabletop, LLC · Series A Raised $15.0M · modeled $302.7M (est)Mediphore, Inc. · Series A Raised $15.0M · modeled $302.7M (est)iVinci Partners, LLC · Series A Raised $34.8M · modeled $302.7M (est)Oklahoma Proton Center LLC · Series A Raised $14.0M · modeled $282.5M (est)MicroOptx, Inc. · Series A Raised $17.8M · modeled $278.6M (est)ProxsysRx, Inc. · Series A Raised $14.6M · modeled $260.0M (est)Biolux Research Holdings, Inc. · Series A Raised $12.7M · modeled $256.3M (est)Fountain Life Holdings, LLC · Series A Raised $17.1M · modeled $238.6M (est)Equality Management Holdings, LLC · Series A Raised $14.4M · modeled $232.3M (est)Olympus Ascent Investors, LLC · Series A Raised $11.5M · modeled $232.0M (est)EDS Holdco LLC · Series A Raised $12.3M · modeled $221.5M (est)Zipari, Inc. · Series A Raised $29.6M · modeled $208.3M (est)Check-Cap Ltd (this company) Raised $26.0M · modeled $190.3M (est)Check-Cap Ltd
CompanyStageRaised · realValue · estvs peer med.
InvestCo Tabletop, LLCSeries A$15.0M$302.7M3.00×
Mediphore, Inc.Series A$15.0M$302.7M3.00×
iVinci Partners, LLCSeries A$34.8M$302.7M3.00×
Oklahoma Proton Center LLCSeries A$14.0M$282.5M2.80×
MicroOptx, Inc.Series A$17.8M$278.6M2.76×
ProxsysRx, Inc.Series A$14.6M$260.0M2.58×
Biolux Research Holdings, Inc.Series A$12.7M$256.3M2.54×
Fountain Life Holdings, LLCSeries A$17.1M$238.6M2.36×
Equality Management Holdings, LLCSeries A$14.4M$232.3M2.30×
Olympus Ascent Investors, LLCSeries A$11.5M$232.0M2.30×
EDS Holdco LLCSeries A$12.3M$221.5M2.20×
Zipari, Inc.Series A$29.6M$208.3M2.06×
Check-Cap Ltd this companySeries A$26.0M$190.3M1.89×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.7M2017-05-29$13.5M$66.9M90%
Seed$2.1M2017-11-20$10.7M$52.8M90%
Series A$4.0M2020-04-20$18.2M$80.7M90%
Series A$4.5M2020-04-30$20.5M$90.8M90%
Series A$3.0M2020-05-08$13.6M$60.5M90%
Series A$9.6M2020-07-23$43.8M$190.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.7M2017-05-29
    • First recorded raise — entered as Seed.
    • 2 investors on this round.
  2. Seed$2.1M2017-11-20
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 4 investors on this round.
  3. Series A$4.0M2020-04-20
    • Raised again after 29 mo — slower than the ~14 mo sector norm.
    • Round 1.9× larger than the prior — scaling up.
    • 8 investors on this round.
  4. Series A$4.5M2020-04-30
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 6 investors on this round.
  5. Series A$3.0M2020-05-08
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  6. Series A$9.6M2020-07-23
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 3.2× larger than the prior — scaling up.
    • 9 investors on this round.
Intelligence
2021 ~Q1
Modeled next raise · ~8mo cadence
$28.9M
Modeled next size est.range $18.8M$46.2M
3.2×
Last step-up
$8.2M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Walter Robb10 other2017-05
Mary Jo Gorman3 other2017-05
Tomer Kariv2 other2017-05
Steven Hanley1 other2017-05
William Densel.1 other2017-05
Alex Ovadia2017-05
Boaz Shpigelman2020-04
Clara Ezed2017-11
Israel Hershko2020-04
Joshua Belkar2020-04
Lior Torem2017-05
Mira Rosenzweig2020-04
Vardit Segal2020-04
XiangQian Lin2017-05
XiangQian (XQ) Lin2020-04
Yoav Kimchy2017-05
Yuval Yanai2017-05
Registry & provenance

Check-Cap Ltd is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1610590
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Advanced Icu Care, Inc.Other Health CareSeries A$17.8M$147.8Mnetwork1 shared operator · same sector · same stage
AbsoluteCARE, Inc.Other Health CareSeries A$25.7M$242.6Msame sector · same stage
OptimizeRx CorpOther Health CareSeries A$25.5M$181.6Msame sector · same stage
SwipeSense, Inc.Other Health CareSeries A$27.0M$214.2Msame sector · same stage
Dynatronics CorpOther Health CareSeries A$24.8M$141.3Msame sector · same stage
C D Services of AMERICA, LLCOther Health CareSeries A$27.4M$176.8Msame sector · same stage
CardioInsight Technologies, Inc.Other Health CareSeries A$24.3M$151.3Msame sector · same stage
BehaveCare Inc.Other Health CareSeries A$24.3M$137.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
MedChefs, Inc.Other Health CarePre-Seed$990K82%
Quotient LtdOther Health CareSeries C$918.1M81%
Neatcap, LLCOther Health CarePre-Seed$3.0M81%
Eyecheq Inc.Other Health CareSeed$18.7M81%
Porter Cares, Inc.Other Health CareSeries B$183.9M81%
Scientific Intake Ltd CoOther Health CareSeed$11.3M81%
CareMax, Inc.Other Health CareSeries B$14.1M81%
Luminus Holdings CorpOther Health CareSeries A$100.9M81%
Frequently asked
How much funding has Check-Cap Ltd raised?
Check-Cap Ltd has raised approximately $26.0M in disclosed capital across 6 recorded financing rounds, aggregated from public filings.
What is Check-Cap Ltd's estimated valuation?
Provath's modeled valuation for Check-Cap Ltd is approximately $190.3M (modeled range $12.3M–$1.0B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Check-Cap Ltd at?
Check-Cap Ltd's latest modeled financing stage is Series A. Its most recent recorded round closed around Thu Jul 23.
What does Check-Cap Ltd do and where is it based?
Check-Cap Ltd operates in the Other Health Care sector, based in ISFIYA.
Explore related

See where Check-Cap Ltd sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Check-Cap Ltd, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.